Allena stock: buy or sell?

ALNA stock price: $1.99 -7.01% At close on February 27th, 2020

Updated on:
February 27th, 2020

0

Shares of Allena closed today at $1.99 and plummed a dreadful -7.01%. On Feb 20th ALNA climbed an amazing 5.65%.

Allena Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, engages in developing and commercializing oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States.

Should I buy Allena stock?

Trading stocks requires experience and discipline, and your buying and selling decisions must come following a methodology. Following a trading strategy helps to make decisions easier, quicker and with less hesitations. At Stocks2.com, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.

Currently, Allena Pharmaceuticals stock doesn't match any of these trading strategies, so our recommendation is not to buy.

Buy setupElegible
New all-time highNo
New 52 week highNo
Price crossing up 200d MANo
100d MA crossing up 200d MANo
This doesn't mean ALNA will fall in coming sessions, or it will not rise higher. Simply, it doesn't match our recommended trading systems.

Is Allena Pharmaceuticals stock a buy?

Everyday, hundreds of stock ratings are published by financial analysts to indicate a particular stock's attractiveness. Unfortunately, we couldn't find any rating for ALNA stock for the last 30 days.

Allena stock analysis

Daily outlook

Shares of Allena Pharmaceuticals plummed a dreadful -7.01% and closed at $1.99.

Allena Pharmaceuticals plummed a dreadful -7.01% and closed at $1.99. Since November when ALNA stock price broke down the SMA200d line, it slid $-3.86 per share (-65.98%). ALNA marked a lower low and a lower high in the short term, defining a downward trend. Climbing above $2.38 would break this short term down trend and open possibilities for reversing this situation.

ALNA stock chart (daily)

Weekly outlook

Shares of Allena Pharmaceuticals plummed a bloodcurdling -7.87% this week. Late January ALNA boosted an exceptional 8.24% in just one week.

Allena finally dropped through the support and now is sliding further into lower prices looking for new supports.

ALNA stock chart (weekly)

Allena stock price history

Allena IPO was on November 2nd, 2017 at $12.40 per share1. Since then, ALNA stock sliced a -84.00%, with a yearly average of -42.00%.

1: Adjusted price after possible price splits or reverse-splits.

Allena stock historical price chart

ALNA stock reached 52-week highs on March at $7.95, and all-time highs 2018-04-03 with a price of 17.56.

Allena stock price target

Predicting the price evolution of a stock or any financial instrument in a reliable and repeatable way is probably impossible. However, banks and other financial institutions analysts, with the help of lots of data and algorithms do their best to predict the stock prices movement. You should not follow the analysts' ALNA stock price predictions in the hope that they will be met as they may be wrong and not met. For the last month we have not found any price forecast for Allena stock by any trusted analyst.

Financials and fundamental analysis

Earnings date and Earnings per Share

On March, Allena failed to meet the forecasts of the analysts and posted a tragic EPS of $-0.46 per share when experts were expecting $-0.51.
ALNA earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise
0000-Q1-n/an/an/a
0000-Q2-n/an/an/a
2017-Q3-n/an/an/a
2017-Q42018-03-27-0.27-0.48n/a
2018-Q12018-05-08-0.45-0.38n/a
2018-Q22018-08-07-0.41-0.42n/a
2018-Q32018-11-07-0.48-0.46n/a
2018-Q42019-03-07-0.51-0.46n/a
2019-Q1-n/an/an/a
2019-Q2-n/an/an/a

Annual financial results

In , Allena annual revenues to M USD from marked in . , its earnings margin (compared to revenues) to , that is million.

ALNA annual Sales and Income evolution
YearSalesYoYIncome/(margin)YoY

Quarterly financial results

Reported quarter income marked $-9.61 million with a profit margin of . Profit margin stayed stable a 0.00% compared to previous quarter when profit margin was inf%. When comparing sales to same quarter last year, Allena sales marked a neutral movement and remained steady a nan%. Looking back to recent quarterly results, Allena Pharmaceuticals posted 5 positive quarters in a row.
ALNA quarterly Sales and Income evolution
QuarterSales1QoQ2Income1/(margin)QoQ2

Allena ownership

When you are planning to buy shares of a stock, it's worth to overview its ownership structure.

Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Allena Pharmaceuticals, 12.46% of all outstanding shares are owned by its staff.

In case of Allena stock, 74.99% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for ALNA stock account 0.00%, no big difference from last month.

The following table compares ownership indicators for other stocks related to Allena Pharmaceuticals:

ALNA
Market cap$46.7 M
Total shares23.5 M
Float shares13.4 M
  - Institutional holdings (%)75.0%
  - Insider holdings (%)12.5%
Shares in short selling0.0%

Allena summary

Thursday, February 27th, 2020
Open$2.00
Close$1.99
Day range$1.93 - $2.08
Previous close$2.14
Session gain-7.01%
Average true range$0.25
50d mov avg$2.43
100d mov avg$2.95
200d mov avg$3.67
Daily patternlb06a
Weekly pattern lt01c

Allena performance

To better understand Allena performance you must compare its gains with other related stocks in same sector or industry. For Allena Pharmaceuticals, the benchmark is made against .
Stock3m6m12m
ALNAAllena Pharmaceut...-9.95%-52.28%-70.86%

Allena competitors

Unfortunately, we could not find any public company that could be defined as Allena Pharmaceuticals competitor. This doesn't mean Allena Pharmaceuticals does not have any competitor in the market, it's just we could not detected it.